Epidemiologic Study Evaluating Infections in Elderly Patients

Back to Search
Print
Bookmark Trial

NCT00900952

Last updated date
Back to Search
Print
Bookmark Trial
FOR MORE INFORMATION
Study Location
Mataró, Barcelona, 08304, Spain
See other locations
Contact
1-800-718-1021
[email protected]
Related Links

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
65 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment

- Patients must have at least one sample processed for microbiological diagnosis

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- COPD exacerbation


- Urinary tract infections


- Hospital acquired infections


- Other infections not in inclusion criteria

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

Call Now
pfizer-logoClinical Trials
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
Learn more ›

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Based on your search, you may also be interested in

InfectionVoriconazole as Prophylactic Therapy in Lung Transplant Recipients
NCT00455364
  1. Chicago, Illinois
ALL GENDERS
18 Years+
years
MULTIPLE SITES
InfectionMDR Bacilli Surveillance and Clinical Feature in China
NCT02140853
  1. Guangzhou, Guangdong
ALL GENDERS
18 Years+
years
MULTIPLE SITES
InfectionA Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli
NCT00724919
  1. Miaoli County,
  2. Taichung,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
InfectionStudy Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women
NCT00751764
  1. Plymouth,
Female
21 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Epidemiologic Study Evaluating Infections in Elderly Patients
Official Title Epidemiologic Study of Infections in Elderly Patients
Brief Summary The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Infected elderly patients treated at Internal Medicine wards in Spanish hospitals
Condition Infection
Intervention Other: Clinical record review
Study Groups/Cohorts 1
Infected elderly patients
Intervention: Other: Clinical record review
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: October 8, 2009)		240
Original Estimated Enrollment
 (submitted: May 12, 2009)		500
Actual Study Completion Date June 2009
Actual Primary Completion Date June 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion criteria:

  • Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment
  • Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria:

  • COPD exacerbation
  • Urinary tract infections
  • Hospital acquired infections
  • Other infections not in inclusion criteria
Sex/Gender
Sexes Eligible for Study:All
Ages 65 Years and older   (Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Spain
Removed Location Countries  
 
Administrative Information
NCT Number NCT00900952
Other Study ID Numbers 3074X1-4489
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
Study Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators Not Provided
Investigators
Study Director:Medical MonitorWyeth is now a wholly owned subsidiary of Pfizer
PRS Account Wyeth is now a wholly owned subsidiary of Pfizer
Verification Date October 2009